260 related articles for article (PubMed ID: 19094125)
1. Urticaria pigmentosa associated with acute stress and lesional skin mast-cell expression of CRF-R1.
Theoharides TC; Kempuraj D; Marchand J; Tzianoumis L; Vasiadi M; Katsarou-Katsari A; Makris M; Kalogeromitros D
Clin Exp Dermatol; 2009 Jul; 34(5):e163-6. PubMed ID: 19094125
[TBL] [Abstract][Full Text] [Related]
2. Chronic peripheral administration of corticotropin-releasing factor causes colonic barrier dysfunction similar to psychological stress.
Teitelbaum AA; Gareau MG; Jury J; Yang PC; Perdue MH
Am J Physiol Gastrointest Liver Physiol; 2008 Sep; 295(3):G452-9. PubMed ID: 18635602
[TBL] [Abstract][Full Text] [Related]
3. CD25 expression on cutaneous mast cells from adult patients presenting with urticaria pigmentosa is predictive of systemic mastocytosis.
Hollmann TJ; Brenn T; Hornick JL
Am J Surg Pathol; 2008 Jan; 32(1):139-45. PubMed ID: 18162781
[TBL] [Abstract][Full Text] [Related]
4. Role of corticotropin-releasing hormone and receptor in the pathogenesis of psoriasis.
Zhou C; Yu X; Cai D; Liu C; Li C
Med Hypotheses; 2009 Oct; 73(4):513-5. PubMed ID: 19560286
[TBL] [Abstract][Full Text] [Related]
5. Enhanced expression of SCF in the dermis is a prognostic factor for the regression of urticaria pigmentosa.
Onuma H; Matsui C; Morokashi M
Eur J Dermatol; 1999 Dec; 9(8):629-32. PubMed ID: 10586131
[TBL] [Abstract][Full Text] [Related]
6. Familial urticaria pigmentosa with giant mast cell granules. A clinical, light, and electron microscopic study.
James MP; Eady RA
Arch Dermatol; 1981 Nov; 117(11):713-8. PubMed ID: 7316532
[TBL] [Abstract][Full Text] [Related]
7. Neurotensin serum levels and skin gene expression are increased in atopic dermatitis.
Vasiadi M; Mondolfi AP; Alysandratos KD; Therianou A; Katsarou-Katsari A; Petrakopoulou T; Theoharidis A; Miniati A; Theoharides TC
Br J Dermatol; 2013 Sep; 169(3):695-9. PubMed ID: 24033157
[TBL] [Abstract][Full Text] [Related]
8. Corticotropin-releasing hormone receptor-1 and histidine decarboxylase expression in chronic urticaria.
Papadopoulou N; Kalogeromitros D; Staurianeas NG; Tiblalexi D; Theoharides TC
J Invest Dermatol; 2005 Nov; 125(5):952-5. PubMed ID: 16297195
[TBL] [Abstract][Full Text] [Related]
9. Chronic stress-induced alterations in amygdala responsiveness and behavior--modulation by trait anxiety and corticotropin-releasing factor systems.
Sandi C; Cordero MI; Ugolini A; Varea E; Caberlotto L; Large CH
Eur J Neurosci; 2008 Nov; 28(9):1836-48. PubMed ID: 18973598
[TBL] [Abstract][Full Text] [Related]
10. Stress neuropeptides evoke epithelial responses via mast cell activation in the rat colon.
Santos J; Yates D; Guilarte M; Vicario M; Alonso C; Perdue MH
Psychoneuroendocrinology; 2008 Oct; 33(9):1248-56. PubMed ID: 18691825
[TBL] [Abstract][Full Text] [Related]
11. Gastrointestinal dysfunction induced by early weaning is attenuated by delayed weaning and mast cell blockade in pigs.
Moeser AJ; Ryan KA; Nighot PK; Blikslager AT
Am J Physiol Gastrointest Liver Physiol; 2007 Aug; 293(2):G413-21. PubMed ID: 17525151
[TBL] [Abstract][Full Text] [Related]
12. [Ultrastructural findings in tissue mast cells in urticaria pigmentosa].
Schmidt U; Leder LD
Z Hautkr; 1988 Aug; 63(8):651-7. PubMed ID: 3188605
[TBL] [Abstract][Full Text] [Related]
13. Mastocytosis with urticaria pigmentosa and osteoporosis.
Stein JA; Kamino H; Walters RF; Pomeranz MK
Dermatol Online J; 2008 Oct; 14(10):2. PubMed ID: 19061601
[TBL] [Abstract][Full Text] [Related]
14. [Clinical picture, treatment and histochemical characteristics of polysaccharide and protein components of mast cells in the skin of patients with mastocytosis].
Mel'nikova VS; Lopunova ZhK
Vestn Dermatol Venerol; 1977 Aug; (8):27-30. PubMed ID: 73277
[No Abstract] [Full Text] [Related]
15. Phagocytosis by mast cells in urticaria pigmentosa.
Krüger PG; Nyfors A
Acta Derm Venereol; 1984; 64(5):373-7. PubMed ID: 6208713
[TBL] [Abstract][Full Text] [Related]
16. Mast cells as targets of corticotropin-releasing factor and related peptides.
Theoharides TC; Donelan JM; Papadopoulou N; Cao J; Kempuraj D; Conti P
Trends Pharmacol Sci; 2004 Nov; 25(11):563-8. PubMed ID: 15491778
[TBL] [Abstract][Full Text] [Related]
17. Photochemotherapy (PUVA) in the treatment of urticaria pigmentosa.
Vella Briffa D; Eady RA; James MP; Gatti S; Bleehen SS
Br J Dermatol; 1983 Jul; 109(1):67-75. PubMed ID: 6860573
[TBL] [Abstract][Full Text] [Related]
18. Treatment of urticaria pigmentosa with corticosteroids.
Barton J; Lavker RM; Schechter NM; Lazarus GS
Arch Dermatol; 1985 Dec; 121(12):1516-23. PubMed ID: 4062333
[TBL] [Abstract][Full Text] [Related]
19. Contribution of stress to asthma worsening through mast cell activation.
Theoharides TC; Enakuaa S; Sismanopoulos N; Asadi S; Papadimas EC; Angelidou A; Alysandratos KD
Ann Allergy Asthma Immunol; 2012 Jul; 109(1):14-9. PubMed ID: 22727152
[TBL] [Abstract][Full Text] [Related]
20. Response of cutaneous mast cells to PUVA in patients with urticaria pigmentosa: histomorphometric, ultrastructural, and biochemical investigations.
Kolde G; Frosch PJ; Czarnetzki BM
J Invest Dermatol; 1984 Sep; 83(3):175-8. PubMed ID: 6470520
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
